Lawmakers in a EU parliamentary committee on Tuesday voted to extend the exclusivity period for new medicines compared to an initial draft, seeking to address concerns expressed across the bloc’s pharma industry as part of a wider regulatory overhaul.
Tag Archive for: EU Commission
The commission fined companies for participating in a cartel aimed at fixing the minimum price of an ingredient to produce the abdominal antispasmodic drug Buscopan and its generic versions.
Europe’s pharmaceutical sector could lose out to increased competition from emerging markets, China and the U.S. in terms of research and innovation if a proposed European Union health package is not amended, its key industry group said on Thursday.
The European Medicines Agency said it is asking healthcare providers to conduct liver tests on patients treated with Zolgensma, after recent reports of deaths related to the gene therapy.
While some companies say the products they have cut have no impact on patients or profits, others say some of the withdrawn devices are essential, and doctors agree.
